Skip to main content
. 2020 Oct 15;11:566548. doi: 10.3389/fendo.2020.566548

Table 2.

Physical activity, dietary intake and free-living CGM variables measured for 24 h before each experimental trial.

Pre-trial standardizations
CON NG-Ex HG-Ex FG-Ex
Dietary intake
 Energy intake, kcals 2250.3 ± 164.1 2116.3 ± 141.1 2043.8 ± 155.4 2080.5 ± 169.0
 Carbohydrate intake (% of kcals) 47.0 ± 4.0 49.4 ± 4.6 47.0 ± 3.7 48.2 ± 4.3
 Fat intake (% of kcals) 35.9 ± 2.0 33.5 ± 2.4 35.7 ± 2.1 34.7 ± 2.2
 Protein intake (% of kcals) 17.1 ± 2.5 17.1 ± 2.4 17.3 ± 2.1 17.0 ± 2.4
Physical activity
 Step count, steps 10715 ± 1893 10722 ± 1725 10032 ± 1746 10229 ± 2048
 Energy expenditure, kcals 587.9 ± 132.9 554.4 ± 115.1 529.1 ± 109.3 562.4 ± 122.3
 Sedentary time, min 726.0 ± 67.6 619.1 ± 86.8 685.8 ± 72.4 753.1 ± 71.7
 MVPA time, min 72.3 ± 17.2 70.8 ± 14.7 66.3 ± 13.9 68.9 ± 18.0
CGM-derived variables
 Mean 24 h glucose, mmol/L 5.2 ± 0.3 5.4 ± 0.1 5.5 ± 0.2 5.2 ± 0.1
 Glucose variability, SD 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.7 ± 0.1
 Glucose variability, CV% 17.0 ± 1.4 14.7 ± 0.8 16.4 ± 1.7 13.7 ± 0.9

Data are mean ± SEM. No significant between-trial differences.